About: Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology
Creator	Messa, Piergiorgio Nordio, Maurizio Reboldi, Gianpaolo Quintaliani, Giuseppe Anteo, · Filippo Aucella, · Giuliano Brunori, · Limido, · Napoli, Di
Source	Medline; PMC
abstract	BACKGROUND: Between February and April 2020, Italy experienced an overwhelming growth of the COVID-19 pandemic. Little is known, at the country level, where and how patients on renal replacement therapy (RRT) have been mostly affected. METHODS: Survey of the network of Nephrology centers using a simplified 17 items electronic questionnaire designed by Italian Society of Nephrology COVID-19 Research Group. We used spatial epidemiology and geographical information systems to map SARS-CoV-2 spread among RRT patients in Italy. RESULTS: On April 9th 2020, all nephrology centers (n = 454) listed in the DialMap database were invited to complete the electronic questionnaire. Within 11 days on average, 365 centers responded (80.4% response rate; 2.3% margin of error) totaling 60,441 RRT patients. The surveyed RRT population included 30,821 hemodialysis (HD), 4139 peritoneal dialysis (PD), and 25,481 transplanted (Tx) patients respectively. The proportion of SARS-CoV-2 positive RRT patients in Italy was 2.26% (95% CI 2.14–2.39) with significant differences according to treatment modality (p < 0.001). The proportion of patients positive for SARS-CoV-2 was significantly higher in HD (3.55% [95% CI 3.34–3.76]) than PD (1.38% [95% CI 1.04–1.78] and Tx (0.86% [95% CI 0.75–0.98]) (p < 0.001), with substantial heterogeneity across regions and along the latitude gradient (p < 0.001). In RRT patients the highest rate was in the north-west (4.39% [95% CI 4.11–4.68], followed by the north-east (IR 2.06% [1.79–2.36]), the center (0.91% [0.75–1.09]), the main islands (0.67% [0.47–0.93]), and the south (0.59% [0.45–0.75]. During the COVID-19 pandemic, among SARS-Cov-2 positive RRT patients the fatality rate was 32.8%, as compared to 13.3% observed in the Italian population as of April 23rd. CONCLUSIONS: A substantial proportion of the 60,441 surveyed RRT patients in Italy were SARS-Cov-2 positive and subsequently died during the exponential phase of COVID-19 pandemic. Infection risk and rates seems to differ substantially across regions, along geographical latitude, and by treatment modality. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40620-020-00794-1) contains supplementary material, which is available to authorized users.
has issue date	2020-07-03(xsd:dateTime)
bibo:doi	10.1007/s40620-020-00794-1
bibo:pmid	32621109
has license	no-cc
sha1sum (hex)	95fad13fafd43459a261beefacd0a36db2e664bb
schema:url	https://doi.org/10.1007/s40620-020-00794-1
resource representing a document's title	Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology
has PubMed Central identifier	PMC7333370
has PubMed identifier	32621109
schema:publication	J Nephrol
resource representing a document's body	covid:95fad13fafd43459a261beefacd0a36db2e664bb#body_text
is schema:about of	named entity 'questionnaire' named entity 'population' named entity 'transplanted' named entity 'patients' named entity 'positive' named entity 'geographical' named entity 'invited' named entity 'Exposure' named entity 'SIGNIFICANT' named entity '60%' named entity 'FOLLOWED BY' named entity 'MARGIN' named entity 'RESULTS' named entity 'HIGHER' named entity 'HAVE' named entity 'POPULATION' named entity 'ERROR' named entity 'TRANSPLANTED' named entity 'USED' named entity 'NETWORK' named entity 'ITALIAN' named entity 'Italian' named entity 'Italy' named entity 'risk' named entity 'RRT' named entity 'RRT' named entity 'RRT' named entity 'positive' named entity 'Infection' named entity 'pandemic' named entity 'Little' named entity 'response rate' named entity 'days' named entity 'listed' named entity 'During' named entity 'pandemic' named entity 'died' named entity 'RRT' named entity 'responded' named entity '95% CI' named entity '95% CI' named entity 'spatial epidemiology' named entity 'RRT' named entity 'SARS-CoV-2' named entity 'SARS-Cov-2' named entity 'RRT' named entity 'COVID-19 pandemic' named entity 'heterogeneity' named entity 'Italy' named entity 'margin of error' named entity 'database' named entity 'RRT' named entity 'Nephrology' named entity 'renal replacement therapy' named entity 'Research Group' named entity 'SARS-CoV-2' named entity 'infection' named entity 'telephone triage' named entity 'ethical standards' named entity 'Italy' named entity 'telemedicine' named entity 'COVID' named entity 'COVID' named entity 'e-mail' named entity 'SARS-CoV-2' named entity 'polymerase chain reaction' named entity 'death rates' named entity 'SARS-CoV-2' named entity 'treatment modality' named entity 'Vienna' named entity 'non-probability sampling' named entity 'margin of error' named entity 'health-care'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software